Terms: = Endocrine gland cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Treatment
441 results:
1. Machine learning developed a fibroblast-related signature for predicting clinical outcome and drug sensitivity in ovarian cancer.
Fu W; Feng Q; Tao R
Medicine (Baltimore); 2024 Apr; 103(16):e37783. PubMed ID: 38640321
[TBL] [Abstract] [Full Text] [Related]
2. A Comparison of Spatial and Phenotypic Immune Profiles of Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions.
Enzler T; Shi J; McGue J; Griffith BD; Sun L; Sahai V; Nathan H; Frankel TL
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474199
[TBL] [Abstract] [Full Text] [Related]
3. An exosome-derived lncRNA signature identified by machine learning associated with prognosis and biomarkers for immunotherapy in ovarian cancer.
Cui Y; Zhang W; Lu W; Feng Y; Wu X; Zhuo Z; Zhang D; Zhang Y
Front Immunol; 2024; 15():1228235. PubMed ID: 38404588
[TBL] [Abstract] [Full Text] [Related]
4. Periostin is associated with prognosis and immune cell infiltration in pancreatic adenocarcinoma based on integrated bioinformatics analysis.
Chen Y; Zhang F; Zhang B; Trojanowicz B; Hämmerle M; Kleeff J; Sunami Y
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1990. PubMed ID: 38389400
[TBL] [Abstract] [Full Text] [Related]
5. Does the choice of platinum doublet matter? A study to evaluate the impact of platinum doublet choice for treatment of platinum-sensitive ovarian cancer recurrence on the development of future PARP inhibitor and platinum resistance.
Levine MD; Wang H; Sriram B; Khan A; Senter L; McLaughlin EM; Bixel KL; Chambers LM; Cohn DE; Copeland LJ; Cosgrove CM; Nagel CI; O'Malley DM; Backes FJ
Gynecol Oncol; 2024 Mar; 182():51-56. PubMed ID: 38262238
[TBL] [Abstract] [Full Text] [Related]
6. An overview of up-and-coming immune checkpoint inhibitors for pancreatic cancer.
Mahadevia H; Uson Junior PLS; Wang J; Borad M; Babiker H
Expert Opin Pharmacother; 2024; 25(1):79-90. PubMed ID: 38193476
[TBL] [Abstract] [Full Text] [Related]
7. [
Zhi Y; Higuchi T; Hackenberg S; Hagen R; Stöth M; Scherzad A; Buck AK; Werner RA; Serfling SE
Endocrine; 2024 May; 84(2):656-662. PubMed ID: 38133766
[TBL] [Abstract] [Full Text] [Related]
8. [Killing effect of anti-MSLN-iCAR-NK cells derived from induced pluripotent stem cells on ovarian epithelial cancer cells].
Fan RJ; Zhang YF; Wang YY; Wang Y; Zheng W
Zhonghua Fu Chan Ke Za Zhi; 2023 Dec; 58(12):922-929. PubMed ID: 38123198
[No Abstract] [Full Text] [Related]
9. Clinical Spectrum of USP8 Pathogenic Variants in Cushing's Disease.
Rebollar-Vega RG; Zuarth-Vázquez JM; Hernández-Ramírez LC
Arch Med Res; 2023 Dec; 54(8):102899. PubMed ID: 37925320
[TBL] [Abstract] [Full Text] [Related]
10. Bilateral inferior petrosal sinus sampling: validity, diagnostic accuracy in lateralization of pituitary microadenoma, and treatment in eleven patients with Cushing's syndrome - a single-center retrospective cohort study.
Ardakani MT; Rabizadeh S; Yadegar A; Mohammadi F; Reyhan SK; Qahremani R; Ghanaati H; Esteghamati A; Nakhjavani M
BMC Endocr Disord; 2023 Oct; 23(1):232. PubMed ID: 37872539
[TBL] [Abstract] [Full Text] [Related]
11. Intensity-modulated radiotherapy for cushing's disease: single-center experience in 70 patients.
Lian X; Xu Z; Sun S; Wang W; Zhu H; Lu L; Hou X; Zhang F
Front Endocrinol (Lausanne); 2023; 14():1241669. PubMed ID: 37822603
[TBL] [Abstract] [Full Text] [Related]
12. Clinical features, diagnosis and treatment outcomes of Cushing's disease in children: A multicenter study.
Tarçın G; Çatlı G; Çetinkaya S; Eren E; Kardelen AD; Akıncı A; Böber E; Kara C; Yıldırım R; Er E; Polat R; Özhan B; Yıldız M; Kor Y; Evliyaoğlu O; Dündar B; Ercan O
Clin Endocrinol (Oxf); 2024 Jan; 100(1):19-28. PubMed ID: 37814958
[TBL] [Abstract] [Full Text] [Related]
13. Pro-tumor Tfh2 cells induce detrimental IgG4 production and PGE
De Monte L; Clemente F; Ruggiero E; Pini R; Ceraolo MG; Schiavo Lena M; Balestrieri C; Lazarevic D; Belfiori G; Crippa S; Balzano G; Falconi M; Doglioni C; Bonini C; Reni M; Protti MP
EBioMedicine; 2023 Nov; 97():104819. PubMed ID: 37776595
[TBL] [Abstract] [Full Text] [Related]
14. Does subtotal resection ameliorate hypothalamic morbidity in pediatric craniopharyngioma? A 30-year retrospective cohort study.
Yousuf OK; Salehani A; Zimmerman K; Estevez-Ordonez D; Madura C; Arynchyna-Smith A; Johnston JM; Rozzelle CJ; Rocque BG; Blount JP
J Neurosurg Pediatr; 2023 Nov; 32(5):569-575. PubMed ID: 37728405
[TBL] [Abstract] [Full Text] [Related]
15. Scoulerine promotes cytotoxicity and attenuates stemness in ovarian cancer by targeting PI3K/AKT/mTOR axis.
Wang F; Zhang Y; Pang R; Shi S; Wang R
Acta Pharm; 2023 Sep; 73(3):475-488. PubMed ID: 37708956
[TBL] [Abstract] [Full Text] [Related]
16. Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas.
Sekizaki T; Kameda H; Nakamura A; Kuwabara S; Nomoto H; Cho KY; Ishi Y; Motegi H; Miyoshi H; Atsumi T
Pituitary; 2023 Oct; 26(5):597-610. PubMed ID: 37642928
[TBL] [Abstract] [Full Text] [Related]
17. Strategies to synergize PD-1/PD-L1 targeted cancer immunotherapies to enhance antitumor responses in ovarian cancer.
Zhao L; Chen X; Wu H; He Q; Ding L; Yang B
Biochem Pharmacol; 2023 Sep; 215():115724. PubMed ID: 37524205
[TBL] [Abstract] [Full Text] [Related]
18. Immune checkpoints as potential theragnostic biomarkers for epithelial ovarian cancer.
Habel A; Weili X; Hadj Ahmed M; Stayoussef M; Bouaziz H; Ayadi M; Mezlini A; Larbi A; Yaacoubi-Loueslati B
Int J Biol Markers; 2023 Dec; 38(3-4):203-213. PubMed ID: 37518940
[TBL] [Abstract] [Full Text] [Related]
19. Evaluating the biological effectiveness of boron neutron capture therapy by using microfluidics-based pancreatic tumor spheroids.
Yu LY; Hsu CH; Li CY; Hong SY; Chen CR; Chen CS
Analyst; 2023 Jun; 148(13):3045-3056. PubMed ID: 37272284
[No Abstract] [Full Text] [Related]
20. Interplay between MAP kinases and tumor microenvironment: Opportunity for immunotherapy in pancreatic cancer.
Kumar S; Singh SK; Srivastava P; Suresh S; Rana B; Rana A
Adv Cancer Res; 2023; 159():113-143. PubMed ID: 37268394
[TBL] [Abstract] [Full Text] [Related]
[Next]
